Literature DB >> 6835271

Hypertension control at the work site. Comparison of screening and referral alone, referral and follow-up, and on-site treatment.

A Foote, J C Erfurt.   

Abstract

Four methods for improving hypertension control among employees were tested in one manufacturing plant each: screening and referral to a physician but no other intervention; referral to a physician and semiannual follow-up; referral to a physician and more frequent follow-up as needed; and on-site treatment or care by a family physician. All methods significantly increased the proportion of subjects under treatment, but only the three programs offering follow-up or treatment significantly improved the adequacy of control. At the end of the three years of the project, 56 to 62 per cent of the hypertensive employees in these three programs had blood-pressure readings below 140/90 mm Hg, and 86 to 90 per cent had readings below 160/95. In contrast, among employees who received no intervention after screening, only 21 per cent had readings below 140/90 mm Hg at the end of the study, and only 47 per cent had readings below 160/95. Employees selecting on-site treatment had the highest level of blood-pressure control, but this finding appeared to be due to self-selection of previously untreated patients into on-site treatment and to exclusion of employees with other medical problems. We conclude that work-site hypertension programs can produce substantial improvements in blood-pressure control if they include systematic, routine follow-up that provides employees with information about their condition and offers support for maintenance of therapy.

Entities:  

Mesh:

Year:  1983        PMID: 6835271     DOI: 10.1056/NEJM198304073081404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  A computerized tool for evaluating the effectiveness of preventive interventions.

Authors:  G Daumit; L E Boulware; N R Powe; C S Minkovitz; K D Frick; L A Anderson; G R Janes; R S Lawrence
Journal:  Public Health Rep       Date:  2001       Impact factor: 2.792

2.  Implementing long-term EAP follow-up with clients and family members to help prevent relapse-With implications for primary prevention.

Authors:  A Foote; B Googins; M Moriarty; C Sandonato; J Nadolski; C Jefferson
Journal:  J Prim Prev       Date:  1994-12

3.  Worksite-screenings for hypertension with follow-up: experiences from the Munich Blood Pressure Program.

Authors:  H W Hense; U Keil
Journal:  Soz Praventivmed       Date:  1989

4.  The role of academic medicine in patient education. In pursuit of hypertension program problems.

Authors:  T S Inui
Journal:  Bull N Y Acad Med       Date:  1985-03

5.  The role of epidemiology in prevention of hypertension in Israel.

Authors:  J D Kark; R Ban
Journal:  Public Health Rep       Date:  1984 May-Jun       Impact factor: 2.792

6.  Changes in coronary risk profiles in employees after three years of multifactorial intervention.

Authors:  M A Martínez-González; A Bueno-Cavanillas; F Sánchez-Izquierdo; I Aguinaga Ontoso; J J Jiménez-Moléon; M Delgado-Rodríguez
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

7.  The determinants of hypertension awareness, treatment, and control in an insured population.

Authors:  D H Stockwell; S Madhavan; H Cohen; G Gibson; M H Alderman
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

8.  The unit of analysis error in studies about physicians' patient care behavior.

Authors:  G W Divine; J T Brown; L M Frazier
Journal:  J Gen Intern Med       Date:  1992 Nov-Dec       Impact factor: 5.128

9.  Community control of hypertension at work-site: epidemiological data of the Agusta project.

Authors:  R Fogari; G Marasi; A Zoppi; G D Malamani; A Vanasia; G Villa
Journal:  Eur J Epidemiol       Date:  1995-10       Impact factor: 8.082

10.  Job absenteeism and arterial hypertension: results of a hypertension control program.

Authors:  S Ruiz de la Fuente Tirado; P Cortina Greus; J L Alfonso Sanchez; C Saiz Sanchez; A Sabater Pons; J I Gonzalez Arraez; C Cortes Vizcaino
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.